Neodent

Also known as: Neodent Grand Morse

The Brazilian implant brand wholly owned by the Straumann Group and positioned as its largest global challenger, or value, brand.

Key facts

Manufacturer	Straumann GroupVerified spec[1]
Parent company	Straumann Holding AGVerified spec[1]
Country	BrazilVerified spec[2][1]
Headquarters	Curitiba, Brazil, where the Straumann Group also operates an implant and prosthetics manufacturing siteVerified spec[2][1]
Founded	Requires manual verification(Widely reported as 1993, but we have not confirmed this against a primary source)
Ownership	Wholly owned by the Straumann Group. Straumann acquired an initial 49% stake in 2012 and increased it to 100% in 2015Verified spec[2][1]
Manufacturer-described indication	Described by the group as its largest global challenger brand, intended to widen access to implant treatment at a lower price pointManufacturer-reported[1]

Overview

Neodent is the reason Straumann Group appears at both ends of the price range. It is a Brazilian brand acquired in stages — 49% in 2012, full ownership in 2015 — and the group positions it deliberately below the Straumann brand rather than as an equivalent. Sharing an owner does not mean sharing components: Neodent’s Grand Morse platform is its own connection, so a Neodent implant is not restored with Straumann parts. Patients offered “a Straumann Group implant” at an unusually low price are usually being offered Neodent, which is a legitimate product but a different one, and worth having named explicitly on the treatment plan.

Regulatory record

Read this before drawing conclusions. A clearance or certificate means a device may legally be sold in a market. It is not a finding that the implant performs well, and it is not a comparison against other implants. In particular, FDA "clearance" is not FDA "approval" — clearance means the FDA accepted the device as substantially equivalent to one already on the market. What these actually mean →

FDA 510(k) clearance1 record

Cleared as substantially equivalent to a predicate device. Not an FDA approval, and not a finding of safety or effectiveness.

Number	Device	Holder	Date
K133592	NEODENT IMPLANT SYSTEM, TITAMAX TI EX ACQUA AND TI DRIVE ACQUA, TITAMAX SMART EX ACQUA AND DRIVE SMART ACQUA, TITAMAX CM	Neodent USA, Inc.	2014-08-22

Clearance records for Neodent were retrieved from the issuing authority's own database, not from the manufacturer's marketing material. We attribute a clearance to a brand only when the filing holder belongs to that brand's corporate family — third-party clearances for compatible components are excluded, because they belong to the company that made the component, not to Neodent.

Sources

Numbers match the citations beside each claim above.

Primary sources

[1]Straumann Group Annual Report 2025 — Straumann Holding AG, 2026. Accessed 2026-07-21.

Additional references

[2]Straumann increases ownership of Neodent to 100% — DentistryIQ, 2015. Accessed 2026-07-21.